Keywords: ACTB; actin-β; ACTG1; actin-γ1; ADA; American Diabetes Association; Ascl1; achaete-scute homolog 1; BMPR2; bone morphogenetic protein receptor type 2; CCNG2; cyclin G2; CNS; central nervous system; CRKL; CRK-like proto-oncogene adaptor protein; CSNK2A2;